U.S. Office REITs Stock News

LPL Financial Holdings (NasdaqGS:LPLA) is seeing advisor turnover following its acquisition of Commonwealth Financial Network, with about 22.5% of Commonwealth advisors choosing to depart instead of joining the firm. At the same time, LPL has attracted a major advisory duo from Fifth Third Private Bank, overseeing US$2b in client assets and launching Moto Wealth Partners on the LPL platform. LPL Financial sits at the center of the independent advice market, providing brokerage, advisory,...

OFG Bancorp recently announced that its Board of Directors approved a new open-ended US$200 million stock repurchase authorization and raised the regular quarterly cash dividend by 17% to US$0.35 per share, payable on April 15, 2026, to shareholders of record on March 31, 2026. These capital actions, coming alongside the completion of a prior buyback program and higher quarterly earnings, highlight management’s current focus on returning excess capital to shareholders. Against this backdrop,...

If you are wondering whether Goodyear Tire & Rubber's current share price reflects its real worth, you are not alone. This article focuses squarely on what the numbers say about value. The stock recently closed at US$9.45, with returns of 0.9% over the last 7 days, 7.4% over 30 days, 5.9% year to date, and 4.2% over 1 year, while the 3 and 5 year returns of 17.9% and 18.5% declines show a much tougher longer term picture. These mixed returns sit against a backdrop of ongoing interest in the...

How PROG Holdings Stock Has Been Performing PROG Holdings (PRG) has drawn attention after a mixed period for shareholders, with the stock showing a monthly gain along with a past 3‑month advance but a weaker 1‑year total return. Over the past month, the stock return is about 6.5%, while the past 3‑month figure is roughly 10.7%. Year to date, the return is close to 10.6%, but the 1‑year total return reflects a decline of about 21.5%. Looking further back, the 3‑year total return is about...

F5 (FFIV) has just opened its Q1 2026 scorecard with revenue of US$822.5 million and basic EPS of US$3.12, framed against trailing 12 month revenue of about US$3.1 billion and EPS of US$12.23. Over the past year, the company has seen quarterly revenue move from US$766.5 million in Q1 2025 through US$810.1 million in Q4 2025 to US$822.5 million in the latest quarter, while basic EPS tracked from US$2.85 to US$3.30 and now US$3.12. Taken together, this sets up a picture of solid scale with...

Alexandria Real Estate Equities has recently reported large real estate impairment charges of about US$1.72 billion, a quarterly net loss of roughly US$1.08 billion, a sharply reduced dividend, and launched cash tender offers of up to US$800 million for its long-dated senior notes. These moves, combined with class action lawsuits over alleged leasing disclosures and an intensive balance sheet reshaping, mark a critical reset in how the REIT is positioning its life science portfolio and...

If you are wondering whether Pebblebrook Hotel Trust is priced attractively right now, this article will walk through what the current share price could mean for long term investors. The stock last closed at US$11.31, with returns of an 8.9% decline over 7 days, a 1.5% decline over 30 days, a 2.1% decline year to date, a 14.8% decline over 1 year, a 31.8% decline over 3 years, and a 42.6% decline over 5 years. Recent price moves are often influenced by changing expectations around the hotel...

Origin Bancorp, Inc. reported fourth-quarter 2025 net income of US$29.52 million, beating analyst expectations on both revenue and earnings, while net charge-offs fell to US$3.17 million after elevated losses tied to Tricolor Holdings, LLC in the prior quarter. Alongside record net interest income, the company continued returning capital to shareholders through a US$0.15 per-share dividend and completion of a 2.47% share buyback program announced in July 2025. We’ll now examine how this...

Fresh investor attention on ADMA Biologics (ADMA) follows recent commentary highlighting analyst support and interest in its plasma derived therapies for primary humoral immunodeficiency and other unmet medical needs within the biotechnology sector. See our latest analysis for ADMA Biologics. Despite recent enthusiasm, ADMA Biologics’ 1 month share price return of a 14.55% decline and 7 day share price return of a 5.93% decline indicate momentum cooling in the short term. At the same time,...

Wondering if Robinhood Markets at around US$103.40 is priced for its story or for its fundamentals? This article walks through what the numbers say so you can judge the current tag for yourself. The stock has seen mixed performance recently, with a 2.4% decline over the last 7 days and an 11.9% decline over the last 30 days, while still sitting on a 102.2% return over 1 year and a very large gain over 3 years. Recent coverage around Robinhood has focused on its role as a major trading...

Why Li Auto’s latest MEGA delivery milestone matters for shareholders Li Auto (LI) has crossed 30,000 cumulative deliveries of its flagship Li MEGA electric MPV, following a period that included a sizeable recall, putting fresh attention on what this means for the stock today. See our latest analysis for Li Auto. At a share price of $17.15, Li Auto’s 1-day and 7-day share price returns of 2.39% and 6.39% sit against a 90-day share price decline of 16.30% and a 1-year total shareholder return...

Target (NYSE:TGT) is rolling out its largest ever Spring beauty assortment, adding more than 3,000 new products across categories. The retailer is refreshing its in store beauty experience, including layout changes and expanded displays. New exclusive brands are being introduced, alongside a bigger focus on textured haircare to reach a broader customer base. For investors watching NYSE:TGT at a share price of $101.74, this push into a broader and more inclusive beauty offering comes after a...

GRAIL (GRAL) is back on investors’ radar after several analysts recently raised their ratings, pointing to growing interest in the company’s multi cancer early detection platform and its long term potential. See our latest analysis for GRAIL. The recent analyst upgrades come against a backdrop of sharp share price moves, with a 14.93% 1 month share price return and a 10.81% 3 month share price return. The 1 year total shareholder return of 278.77% suggests momentum has been strong despite...

If you are wondering whether Appian's current share price reflects its underlying worth, you are not alone. Many investors are asking the same question right now. The stock recently closed at US$30.21, with returns of 6.3% over the last 7 days, a 15.3% decline over 30 days, an 11.3% decline year to date, a 14.2% decline over 1 year and a 30.5% decline over 3 years, while the 5 year return stands at an 85.4% decline. Recent company news has focused on Appian's position in low code software...

In recent days, Blackstone has drawn attention ahead of its January 29 earnings release, while also ramping up Asia hiring and pursuing deals such as the planned acquisition of Arlington Industries and a potential sale of Beacon Offshore Energy, alongside interest in bidding for IPL franchise Royal Challengers Bengaluru. Together, these moves highlight how Blackstone is reshaping its business mix across private wealth, energy transition and sports assets at a time of shifting market...

If you are wondering whether Cardinal Health's share price still offers value after a strong run, this article walks through what the current numbers might be telling you. The stock last closed at US$210.39, with returns of 0.9% over 7 days, 1.5% over 30 days, 2.3% year to date, 66.7% over 1 year and 193.2% over 3 years. This naturally raises questions about how much of the story is already reflected in the price. Recent news coverage has focused on Cardinal Health's role as a major...

If you are wondering whether Vera Therapeutics at around US$45 a share still offers value, the key question is how its current price compares with what the business might reasonably be worth. The stock has seen a mixed run, with an 18.9% return over the past year but declines of 1.4% over the last week, 13.7% over the last month and 7.2% year to date. This can change how the market views both its potential and its risks. Recent attention on Vera Therapeutics has largely centered on its drug...

Duke Energy (NYSE:DUK) announced the retirement of longtime executive Preston Gillespie after roughly 40 years with the company. Kelvin Henderson has been appointed chief generation officer, taking a central role in decisions around Duke Energy's nuclear generation plans. These leadership changes come as Duke Energy manages widespread power outages linked to Winter Storm Fern and its impact on the grid. Duke Energy, a major regulated utility serving several U.S. regions, is at the center of...

Circle Internet Group (CRCL) is back in focus after Mizuho shifted its rating higher, pointing to rising USDC usage on prediction platform Polymarket. Ark Invest recently added shares, and new institutional stablecoins are sharpening competitive pressure. See our latest analysis for Circle Internet Group. Circle’s recent Mizuho upgrade and Ark Invest buying arrived after a tougher stretch, with the 90 day share price return of 40.64% decline and a year to date share price return of 12.74%...

Recent analyst actions around Xylem (XYL), including rating reaffirmations and increasingly positive outlooks, have brought fresh attention to the water technology stock and prompted investors to reassess its role in their portfolios. See our latest analysis for Xylem. Despite the reaffirmed optimism from analysts, Xylem’s recent trading has been softer, with a 1 day share price return of a 3.48% decline and a 90 day share price return of a 10.57% decline, while its 1 year total shareholder...

Definium Therapeutics recently rebranded and launched its “Rerouting Minds” educational campaign, aimed at explaining the science behind pharmaceutical LSD and its potential role in mental health treatment, underscoring the company’s focus on evidence-based psychedelic therapies. By centering public education on rigorously studied psychedelic treatments, Definium is positioning itself as a science-first voice in an emerging area of psychiatry that is drawing increasing clinical and investor...

Lam Research (LRCX) is back in focus after reporting quarterly revenue and profit above analyst estimates, paired with guidance that points to higher expected sales and earnings in the coming quarter. See our latest analysis for Lam Research. The strong quarter and upbeat guidance have come alongside powerful market momentum, with a 36.2% 1 month share price return and a very large 1 year total shareholder return of 221.7%. This suggests enthusiasm is building rather than fading. If Lam...

Gold and silver prices have reached record highs, creating a favorable backdrop for Newmont's precious metals portfolio. Ghana is considering an increase in mining royalties, which could affect Newmont's cost structure in a key operating region. Investors are weighing the benefits of stronger revenues and cash flows against emerging regulatory risks in West Africa. Newmont (NYSE:NEM), trading at $131.95, is operating in a rare environment in which both gold and silver prices sit at all-time...

Freddie Mac OTCPK:FMCC released its Monthly Volume Summary for December 2025, detailing recent activity across its mortgage portfolio. New preliminary ratings were assigned by KBRA to Freddie Mac mortgage pass through certificates, linked to recent securitization activity. The latest Monthly Volume Summary provides a closer look at how Freddie Mac is managing its book of mortgages, including guarantees and securitizations. As a government sponsored enterprise focused on housing finance, the...